AAOS Now, February 2016
PRP: Does It Do Anything?
Biologics are becoming increasingly popular in the field of orthopaedics for nonsurgical management or as an adjunct to surgical treatments. Media attention to platelet-rich plasma (PRP)—an autologous blood derivative that isolates high concentrations of platelets and is rich in multiple growth factors and cytokines—has given this treatment a starring role. But does the evidence support the multiple touted uses for PRP?
Unintended Consequences of CJR
Bundled payments are not only here to stay, they are now being mandated in specific geographic regions, under the Comprehensive Care for Joint Replacement (CJR) program. Although the intent of this payment strategy is to drive value in health care, a likely unintended consequence may be to decrease access to surgical care for certain high-risk patients.